GWP42003-P ( DrugBank: - )


5 diseases
IDDisease name (Link within this page)Number of trials
140Dorabe syndrome16
144Lennox-Gastaut syndrome14
145West syndrome3
156Rett syndrome7
158Tuberous sclerosis6

140. Dorabe syndrome


Clinical trials : 116Drugs : 65 - (DrugBank : 17) / Drug target genes : 50 - Drug target pathways : 64 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

144. Lennox-Gastaut syndrome


Clinical trials : 111Drugs : 72 - (DrugBank : 14) / Drug target genes : 49 - Drug target pathways : 61 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

145. West syndrome


Clinical trials : 43Drugs : 52 - (DrugBank : 15) / Drug target genes : 28 - Drug target pathways : 26 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

156. Rett syndrome


Clinical trials : 44Drugs : 61 - (DrugBank : 23) / Drug target genes : 57 - Drug target pathways : 83 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

158. Tuberous sclerosis


Clinical trials : 112Drugs : 71 - (DrugBank : 19) / Drug target genes : 35 - Drug target pathways : 118 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries